Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 809 results for "daiichi sankyo company"

Daiichi Sankyo initiates testing of etanercept biosimilar in Japan20-08-2014
Pharma Letter

Daiichi-Sankyo reports higher Q1 profit, provides annual outlook

Daiichi-Sankyo co., ltd, manufacturer of pharmaceuticals, has reported that profit attributable to owners of the company for the first quarter ended June 30, 2014 was JPY19.99 billion, or JPY28.34 per diluted share, compared to JPY15.02 billion, or ..., 7 hours ago

Sun Pharmaceutical banks on Daiichi Sankyo to crack Japan market

NEW DELHI: , which is in the process of acquiring control of Ranbaxy Laboratories from Daiichi Sankyo, will soon put its purchase to work through the exclusive marketing opportunity offered by two drugs in the US, rationalising research and other ...
 Economic Times1 week ago Sun Pharma banks on Daiichi Sankyo to enter Japan market: Reports  India Infoline1 week ago

Sun Pharma likely to enter Japanese market in four years

Sun Pharmaceuticals is reportedly planning to enter the Japanese market riding on its association with Daiichi Sankyo from which it is buying Ranbaxy Laboratories. The Economic Times has reported that the drug company is likely to introduce its ...
 Pharmaceutical Business Review1 week ago Bharat Book Bureau: Global Pharmaceutical and Biotechnology Outlook 2014 - Japan Pharma  Pharmacy Choice6 days ago SUN PLANS TO RISE IN JAPAN'S PHARMA MARKET  Pharmacy Choice1 week ago

Consistency of Signals in Bivalirudin/Heparin Meta-Analysis

BOSTON, MA — Authors of a new meta-analysis comparing a bivalirudin (Angiomax, the Medicines Company)-based regimen vs a heparin-based approach in patients undergoing PCI say they hope their paper helps the medical community to understand the ...
 Diabetes Care5 days ago

Biota Pharma announces positive results from phase 2 IGLOO trial of laninamivir octanoate

Biota Pharmaceuticals, a biopharmaceutical company focused on the discovery and development of products to prevent and treat serious and potentially life-threatening viral respiratory infectious diseases, announced top-line data from a randomised, ...
 PharmaBiz2 weeks ago Biota Reports Top-Line Data From Its Phase 2 "IGLOO" Trial of Laninamivir Octanoate  Stock Nod2 weeks ago News Scan for Aug 01, 2014  Centre For Infectious Disease Research and Policy2 weeks ago Biota Pharma Reports Top-line Data From Laninamivir Octanoate Phase 2 Trial  RTTNews.com2 weeks ago
Financial Express

India's Sun Pharma posts Q1 profit on strong US sales

Sun Pharma's April-June net profit was 13.91 billion rupees ($227.73 million), compared with a net loss of 12.76 billion rupees a year earlier. (Reuters) Summary Sun Pharma's April-June net profit was 13.91 billion rupees ($227.73 million), ...
 Financial Express1 week ago Sun, Ranbaxy hire Mckinsey for merger assistance  Rediff.com1 month ago Too Big To Ignore  Businessworld India7 hours ago Sun Pharma registers Rs 1391 crores profit in Q1  Bio Spectrum Asia2 days ago

Alzheimer's Disease Therapeutics and Diagnostics Market Forecast 2014-2024: Opportunities for Leading Companies

Alzheimer's medicine - your guide to technologies, trends and revenues Where is the Alzheimer's disease treatment market heading? Visiongain's new report gives you revenue predictions for those drugs and diagnostic tests from 2014, helping ...
 Global Information Inc2 days ago

R348 Did Not Meet Endpoints in Phase 2 Dry Eye Study

SOUTH SAN FRANCISCO, Calif. The Company is focusing its resources on advanced clinical studies of fostamatinib in two indications. The fostamatinib programs include a recently initiated Phase 3 study in patients with immune thrombocytopenic ...
 Industrial Info Financials1 week ago An antidote for Factor Xa inhibitors  Drug Discovery News1 week ago Rigel Announces Second Quarter 2014 Financial Results  Review Seeker2 weeks ago ArQule Reports Second Quarter 2014 Financial Results  Morningstar.com2 weeks ago

PM360 Announces 2014 Trailblazer Award Finalists

Top Healthcare Talent, Companies and Brand Champions to be Honored September 18th New York, NY (PRWEB) August 20, 2014 The finalists are in for the sixth-annual PM360 Trailblazer Awards. PM360, a leading health-marketing industry trade magazine, ...
 BizWire Express5 hours ago 48% of US Physicians Ready for iPhone 6 "Phablet" and 37% Ready for the iWatch  Stock Nod2 weeks ago
FirstWord Pharma

FirstWord Lists: Which companies in the oncology space have the most effective medical affairs teams?

The importance of a sound medical affairs team to the commercial success of a marketed drug cannot be understated, particularly in oncology setting where treatment paradigms are shifting rapidly based on a constant flow of clinical data and ...
 FirstWord Pharma1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less